Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
United States Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A21012
Year End
sale
Buy Now
Market Overview:
United States cancer biomarkers market size is projected to exhibit a growth rate (CAGR) of 11.60% during 2024-2032. The emerging shift towards precision medicine and personalized therapies, which has increased the demand for specific biomarkers that can help identify the most effective treatment options for individual patients, is driving the market.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023 |
|
Forecast Years
|
2024-2032 |
|
Historical Years
|
2018-2023
|
| Market Growth Rate (2024-2032) | 11.60% |
Cancer biomarkers are molecules or genetic alterations that can be objectively measured and indicate the presence of cancer or its potential for development. These markers play a crucial role in cancer diagnosis, prognosis, and treatment. They can be found in various biological substances, such as blood, tissues, or urine. Biomarkers help identify specific cancer types, assess the disease's stage, and predict patient responses to certain therapies. Additionally, they aid in monitoring treatment effectiveness and detecting recurrence. Advances in molecular biology and genomics have led to the discovery of numerous cancer biomarkers, contributing to personalized medicine approaches. By providing valuable information about the molecular characteristics of tumors, cancer biomarkers enhance the understanding of the disease and guide more targeted and effective treatment strategies.
United States Cancer Biomarkers Market Trends:
The cancer biomarkers market in the United States is experiencing robust growth, driven by a myriad of factors that collectively underscore its significance in the field of oncology. Firstly, advancements in genomic and proteomic technologies have catalyzed the identification of novel biomarkers, expanding the repertoire of diagnostic and prognostic tools. Moreover, the escalating incidence of cancer in the United States has intensified the demand for precise and early detection methods, amplifying the market's momentum. Furthermore, the increasing emphasis on personalized medicine has propelled R&D efforts to unravel specific biomarkers associated with individual patient profiles. This approach not only enhances diagnostic accuracy but also facilitates targeted therapeutic interventions, fostering market expansion. In addition to this, collaborative initiatives between academic institutions, research organizations, and pharmaceutical companies have accelerated biomarker discovery, creating a symbiotic relationship that propels the market forward. Parallelly, the growing adoption of liquid biopsy techniques, coupled with non-invasive diagnostic methodologies, has contributed significantly to the market's attractiveness. These developments, underpinned by technological innovation, emphasize the pivotal role of cancer biomarkers in revolutionizing cancer diagnosis and treatment strategies. As a result, the regional market is poised for sustained growth, with these interconnected drivers steering its trajectory toward a future characterized by enhanced precision and efficacy in cancer management.
United States Cancer Biomarkers Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application, and end user.
Profiling Technology Insights:
- Omic Technologies
- Imaging Technologies
- Immunoassays
- Cytogenetics
The report has provided a detailed breakup and analysis of the market based on the profiling technology. This includes omic technologies, imaging technologies, immunoassays, and cytogenetics.
Biomolecule Insights:
- Genetic Biomarkers
- Protein Biomarkers
- Glyco-Biomarkers
A detailed breakup and analysis of the market based on the biomolecule have also been provided in the report. This includes genetic biomarkers, protein biomarkers, and glyco-biomarkers.
Cancer Type Insights:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
The report has provided a detailed breakup and analysis of the market based on the cancer type. This includes breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, and others.
Application Insights:
- Diagnostics
- Prognostics
- Risk Assessment
- Drug Discovery and Development
- Others
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics, prognostics, risk assessment, drug discovery and development, and others.
End User Insights:
- Hospitals
- Academic and Research Institutions
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, academic and research institutions, ambulatory surgical centers, diagnostic laboratories, and others.
Regional Insights:
- Northeast
- Midwest
- South
- West
The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
United States Cancer Biomarkers Market Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | US$ Million |
| Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
| Profiling Technologies Covered | Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics |
| Biomolecules Covered | Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers |
| Cancer Types Covered | Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others |
| Applications Covered | Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, Others |
| End Users Covered | Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, Others |
| Regions Covered | Northeast, Midwest, South, West |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the United States cancer biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the United States cancer biomarkers market?
- What is the breakup of the United States cancer biomarkers market on the basis of profiling technology?
- What is the breakup of the United States cancer biomarkers market on the basis of biomolecule?
- What is the breakup of the United States cancer biomarkers market on the basis of cancer type?
- What is the breakup of the United States cancer biomarkers market on the basis of application?
- What is the breakup of the United States cancer biomarkers market on the basis of end user?
- What are the various stages in the value chain of the United States cancer biomarkers market?
- What are the key driving factors and challenges in the United States cancer biomarkers?
- What is the structure of the United States cancer biomarkers market and who are the key players?
- What is the degree of competition in the United States cancer biomarkers market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States cancer biomarkers market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the United States cancer biomarkers market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States cancer biomarkers industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More